Epitalón
Tetrapeptide (Ala-Glu-Asp-Gly)
Tetrapeptide with longevity hypotheses and very limited evidence.
Back to technical sheets- Class
- Tetrapeptide (Ala-Glu-Asp-Gly)
- Also known as
- Research compound; longevity claims unconfirmed
Mechanism of action
It is proposed to modulate telomerase activity and pineal/melatonin function. Data are limited and come mostly from a small number of research groups.
Evidence
Preclinical and small studies of low methodological quality. Longevity claims are not confirmed by robust trials. Not approved.
Studied uses
- None approved (longevity hypotheses under study)
Safety considerations
- Very limited, low-quality evidence
- No robust trials supporting the claims
- Not approved for human use
Batch quality data
We publish these figures because they are the ones the program itself teaches you to ask for.
- Purity
- ≥ 98 % (HPLC)
- Net content
- 84 %
- Batch
- EPI-2601
- Presentation
- Polvo liofilizado en vial sellado
Net content is the fraction of the vial’s weight that is actually peptide, after discounting water, salts and excipients. It is the figure to calculate with, not the label weight.
Sample prices and batch data while the real ones are loaded.
Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.